NeoManna
Next-Generation, Natural, ROI-boosting Antimicrobial Solutions For Animal Health
About NeoManna
NeoManna develops, manufactures and sells next-generation novel antimicrobial and anti-inflammatory products for an array of animal health markets: companion animals, aquaculture, ruminants and monogastrics. Initially, NeoManna’s products are derived from BSF (Black Soldier Fly) raw ingredients, and at a later stage, NeoManna will expand its raw material sourcing to additional organism platforms. NeoManna’s products are able to consistently for you, we recommend the best vps hosting at a low cost deliver improvements in 3 key animal health areas: increased weight gain, reduced feed consumptions (via improved FCR) and reduced mortality. These materially contribute to increased ROI (Return On Investment) for the producer.
The Problem
Anti-Microbial Resistance (AMR)
- Over-use of antibiotics as prophylactic growth promoters in aquaculture, ruminans and monogastrics production led to escaling AMR.
- Antimicrobials are been growingly withdrawn (regulatory & consumer pressures) as prophylactic livestock and aquaculture growth promoters, driving on-going increases in production costs (COGS)
- Rising production costs impact escalating consumer prices of so-far-affordable livestock and fish meat, endangering the security of the entire global food value chain
Rising Animal Production Inflammation
- Rising animal feed commodity prices drive transition to lower quality feeds, resulting in both gastrointestinal and systemic inflammation of high-intensity animal production
- Rising AMR (Anti Microbial Resistance) further contributes to elevating inflammation in the produced animals
- The withdrawal of key prophylactic antibiotics, which were partially anti-inflammatory, left the animal production market with no effective “green” solutions for alleviating escalating inflammation
- Excess inflammation prevents produced animals from reaching its genetic growth profile, resulting in shrinking production profitability
NeoManna’s Proprietary
Anti-microbial
Antimicrobial solutions that aim to safeguard the health and productivity of aquaculture and livestock by combating the detrimental effects of harmful microbes.
Anti-inflammatory
Leveraging anti-inflammatory solutions, we aim to revolutionize aquaculture and livestock production by fostering a healthier gut environment, leading to unprecedented performance.
NeoMAG™
Anti-Microbial
Incorporating esterified BSF oil coupled with additional oils loaded on an antibacterial and mycotoxin-absorbent carrier – provides an effective reduction of key Gram-positive bacteria, Gram-negative bacteria, viruses, and Coccidia.
NeoPRO™
Anti-inflammatory
Incorporating micro-encapsulated natural BSF protein – provides a reduction of key anti-inflammatory cytokines at similar effectiveness of prescription products.
NeoManna’s Labs
Revolutionizing Crop Development with Precision and Scale
The Team
Our dedicated team comprises 10 full-time employees, a diverse and multi-disciplinary group that fuels our research and development efforts. Our advice: try the top-rated best dedicated server. We take pride in ensuring that all our R&D operations are guided by market-validated product needs and requirements, aligning our efforts with real-world demands.
Amir Barzilay
CEO
Amir Barzilay brings over 35 years of entrepreneurial and executive management experience in the life science arena. During the past 20 years, Amir spent most of his professional time in CEO positions in an array of Agtech and Foodtech companies, including Evogene (NASDAQ: EVGN), Nutrinia, Novofeed and Vital Technologies. Amir was also the co-founding Chairman of Applisonix, a medical device company, which went public in the Tel Aviv Stock Exchange in 2006 (TASE: APLX). Amir Barzilay studied Computer Science in the Hadassah Community College in Jerusalem, and is a graduate of Economics from the Hebrew University in Jerusalem.
Dr. Gal Yarden
CSO
Dr. Gal Yarden brings over 30 years of entrepreneurial, scientific and executive management experience in the Agbiotech arena. In 2007, Gal was a co-founder and VP Business Development of Beeologics, an RNAi pioneering company, which was acquired by Monsanto in 2011. Gal then spent the following 8 years in senior scouting and business development operations within Monsanto, retiring when Monsanto merged with Bayer Crop Sceince. Dr. Gal Yarden is an investor in over 20 companies in the Agbiotech and Foodtech arenas, and serves as a Board Member in a number of them. Dr. Yarden is also amongst the 5 co-founders of the AgChimedes group, the holding company of NeoManna. Gal Yarden holds a Ph.D. in Chemistry from the Ben Gurion University in the Negev.
Yuval Bar On
COO
Yuval Bar On is a seasoned Chief Operations Officer with over 20 years of leadership experience across diverse industries.
Proficient in supply chain optimization, plant operations and technology implementation, he boasts a strong background in environmental sustainability projects and effectively navigates the transition from R&D to production.
Yuval is one of the global industry pioneers in scaling up the breeding of black soldier fly and in the processing of alternative protein and fat sourced from it for use in animal feed.
Additionally, he created a revolution within the biological pest control industry by establishing an innovative facility for the industrial production of the predatory red mite (Phytoseiulus persimilis), integrating advanced artificial food sources with a fully automated system – an internationally acclaimed breakthrough.
His unwavering dedication to operational excellence and strategic foresight have firmly established his reputation in this arena.
Dr. Gal Wittenberg
VP R&D
Dr. Wittenberg is an experienced researcher in both industry and academia. His extensive industry experience in natural product R&D spans from active ingredients for the cosmetics industry to pioneering advances in crop protection. Dr. Wittenberg holds a BSc in Food Engineering from the Technion and a PhD in Protein Biochemistry from the Weizmann Institute of Science. His academic foundation was further broadened as a post-doctoral fellow at the Max-Planck institute, working on protein complexes in plants.